Rockwell Medical (RMTI) Amortizatization of Intangibles (2022 - 2026)
Rockwell Medical (RMTI) posted Amortizatization of Intangibles of $102000.0 for Q1 2026, up 0.99% on a QoQ basis from $101000.0 in Q4 2025, and down 26.62% year-over-year from $139000.0 in Q1 2025.
Rockwell Medical (RMTI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Rockwell Medical's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $102000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 26.62% year-over-year to $102000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $451000.0 (down 19.03% YoY) and the FY2025 annual result came in at $488000.0, down 12.7% from the prior year.
- Amortizatization of Intangibles was $102000.0 for Q1 2026 at Rockwell Medical, up from $101000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $142000.0 in Q3 2023 and bottomed at $101000.0 in Q4 2025.
- A 5-year average of $133562.5 and a median of $141000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles climbed 0.71% — and 2025, when it retreated 26.81%.
- Rockwell Medical's Amortizatization of Intangibles stood at $141000.0 in 2022, then changed by 0.0% to $141000.0 in 2023, then decreased by 2.13% to $138000.0 in 2024, then fell by 26.81% to $101000.0 in 2025, then grew by 0.99% to $102000.0 in 2026.
- Business Quant data shows RMTI's Amortizatization of Intangibles at $102000.0 in Q1 2026, $101000.0 in Q4 2025, and $109000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |